MPT Medical Properties Trustlimited data
NYSE · Real Estate · Health Care REITs · latest quarter in EDGAR: 2026-03-31
Medical Properties Trust (MPT) is in ThetaGrade’s extended coverage. It does not have a House Rating; this is a fundamentals-only summary from SEC filings, compared with Real Estate peers. Overall its fundamentals read Mixed (Growth: average; Profitability: above average; Balance sheet: below average). 57% of the method weight is backed by data.
Data as of .
Growth
Average| Revenue growth (TTM, YoY) | Average |
| EPS growth (TTM, YoY) | data gap |
Profitability
Above average| Operating margin (TTM) | Above average |
| Free-cash-flow margin (TTM) | data gap |
Balance sheet
Below average| Net debt / EBITDA | Bottom quintile |
| Current ratio | data gap |
| Interest coverage | Below average |
From the filings
- Operating profit (TTM)
- Revenue up year over year
- Net debt
Next earnings
Estimated window 2026-10-18 to 2026-11-09 (rough estimate; estimated from SEC 8-K Item 2.02 filing history (not company-confirmed)). Back-test max error 11 days (> 7).
Why no House Rating
- price under $10
- real estate / REIT
- below the size / liquidity thresholds
House Ratings, Weekly Picks and the CSP screen cover the Tier 1 universe only. Methodology
Get rating changes in the free Daily Brief
The market’s key events and signals, digested before the open.
- ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
- ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
- ✓ OPEX, FOMC, CPI and jobs-day reminders
Free. Want more? See Premium.
Educational summary from public SEC filings; not a House Rating and not financial advice. Sector: GICS (S&P 600, Wikipedia). Source: SEC EDGAR filings. Data as of 2026-10-21.